Abstract
A series of N-phenyl-2,5-dimethylpyrrole derivatives, designed as hybrids of the antitubercular agents BM212 and SQ109, have been synthesized and evaluated against susceptible and drug-resistant mycobacteria strains. Compound 5d, bearing a cyclohexylmethylene side chain, showed high potency against M. tuberculosis including MDR-TB strains at submicromolar concentrations. The new compound shows bacteriostatic activity and low toxicity and proved to be effective against intracellular mycobacteria too, showing an activity profile similar to isoniazid.
Original language | English |
---|---|
Pages (from-to) | 638-644 |
Number of pages | 7 |
Journal | ACS Medicinal Chemistry Letters |
Volume | 11 |
Issue number | 5 |
DOIs | |
State | Published - 14 May 2020 |
Keywords
- Tuberculosis
- antimycobacterial drug
- drug resistance
- intracellular tuberculosis
- pyrroles
All Science Journal Classification (ASJC) codes
- Drug Discovery
- Biochemistry
- Organic Chemistry